0000046129--12-31 2020 Q2 false 0 0 9599000 9744000 true 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2020-04-01 2020-06-30 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2020-01-01 2020-03-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2019-04-01 2019-06-30 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2019-01-01 2019-03-31 0000046129 us-gaap:RetainedEarningsMember 2020-06-30 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-06-30 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-06-30 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2020-06-30 0000046129 us-gaap:RetainedEarningsMember 2020-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-03-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2020-03-31 0000046129 2020-03-31 0000046129 us-gaap:RetainedEarningsMember 2019-12-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2019-12-31 0000046129 us-gaap:RetainedEarningsMember 2019-06-30 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-06-30 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-30 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2019-06-30 0000046129 us-gaap:RetainedEarningsMember 2019-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-03-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2019-03-31 0000046129 2019-03-31 0000046129 us-gaap:RetainedEarningsMember 2018-12-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 0000046129 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000046129 amot:UnamortizedCostOfEquityAwardsMember 2018-12-31 0000046129 us-gaap:RestrictedStockMember 2020-06-30 0000046129 us-gaap:RestrictedStockMember 2019-12-31 0000046129 amot:VestingBasedOnPerformanceMember us-gaap:RestrictedStockMember 2020-04-01 2020-06-30 0000046129 us-gaap:RestrictedStockMember 2020-04-01 2020-06-30 0000046129 amot:OutsideUnitedStatesMember 2020-04-01 2020-06-30 0000046129 amot:ForeignSubsidiariesMember 2020-04-01 2020-06-30 0000046129 amot:OutsideUnitedStatesMember 2020-01-01 2020-06-30 0000046129 amot:ForeignSubsidiariesMember 2020-01-01 2020-06-30 0000046129 amot:OutsideUnitedStatesMember 2019-04-01 2019-06-30 0000046129 amot:ForeignSubsidiariesMember 2019-04-01 2019-06-30 0000046129 amot:OutsideUnitedStatesMember 2019-01-01 2019-06-30 0000046129 amot:ForeignSubsidiariesMember 2019-01-01 2019-06-30 0000046129 srt:EuropeMember 2020-04-01 2020-06-30 0000046129 country:US 2020-04-01 2020-06-30 0000046129 amot:VehicleMember 2020-04-01 2020-06-30 0000046129 amot:OtherTargetMarketMember 2020-04-01 2020-06-30 0000046129 amot:MedicalMember 2020-04-01 2020-06-30 0000046129 amot:IndustrialAndElectronicsMember 2020-04-01 2020-06-30 0000046129 amot:ContinentOfOtherThanUnitedStatesEuropeAndAsiaMember 2020-04-01 2020-06-30 0000046129 amot:AerospaceAndDefenseMember 2020-04-01 2020-06-30 0000046129 srt:EuropeMember 2020-01-01 2020-06-30 0000046129 country:US 2020-01-01 2020-06-30 0000046129 amot:VehicleMember 2020-01-01 2020-06-30 0000046129 amot:OtherTargetMarketMember 2020-01-01 2020-06-30 0000046129 amot:MedicalMember 2020-01-01 2020-06-30 0000046129 amot:IndustrialAndElectronicsMember 2020-01-01 2020-06-30 0000046129 amot:ContinentOfOtherThanUnitedStatesEuropeAndAsiaMember 2020-01-01 2020-06-30 0000046129 amot:AerospaceAndDefenseMember 2020-01-01 2020-06-30 0000046129 srt:EuropeMember 2019-04-01 2019-06-30 0000046129 country:US 2019-04-01 2019-06-30 0000046129 amot:VehicleMember 2019-04-01 2019-06-30 0000046129 amot:OtherTargetMarketMember 2019-04-01 2019-06-30 0000046129 amot:MedicalMember 2019-04-01 2019-06-30 0000046129 amot:IndustrialAndElectronicsMember 2019-04-01 2019-06-30 0000046129 amot:ContinentOfOtherThanUnitedStatesEuropeAndAsiaMember 2019-04-01 2019-06-30 0000046129 amot:AerospaceAndDefenseMember 2019-04-01 2019-06-30 0000046129 srt:EuropeMember 2019-01-01 2019-06-30 0000046129 country:US 2019-01-01 2019-06-30 0000046129 amot:VehicleMember 2019-01-01 2019-06-30 0000046129 amot:OtherTargetMarketMember 2019-01-01 2019-06-30 0000046129 amot:MedicalMember 2019-01-01 2019-06-30 0000046129 amot:IndustrialAndElectronicsMember 2019-01-01 2019-06-30 0000046129 amot:ContinentOfOtherThanUnitedStatesEuropeAndAsiaMember 2019-01-01 2019-06-30 0000046129 amot:AerospaceAndDefenseMember 2019-01-01 2019-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2020-04-01 2020-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2020-01-01 2020-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0000046129 us-gaap:MachineryAndEquipmentMember 2020-06-30 0000046129 us-gaap:LandMember 2020-06-30 0000046129 us-gaap:BuildingAndBuildingImprovementsMember 2020-06-30 0000046129 amot:FurnitureFixturesAndOtherMember 2020-06-30 0000046129 us-gaap:MachineryAndEquipmentMember 2019-12-31 0000046129 us-gaap:LandMember 2019-12-31 0000046129 us-gaap:BuildingAndBuildingImprovementsMember 2019-12-31 0000046129 amot:FurnitureFixturesAndOtherMember 2019-12-31 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-04-01 2020-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2019-04-01 2019-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2019-01-01 2019-06-30 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-04-01 2020-06-30 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-06-30 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-04-01 2019-06-30 0000046129 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-01-01 2019-06-30 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-06-30 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-06-30 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-06-30 0000046129 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-30 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000046129 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000046129 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0000046129 amot:AmendedRevolvingCreditFacilityMember 2020-02-12 0000046129 srt:MinimumMember amot:AmendedRevolvingCreditFacilityMember 2020-02-11 0000046129 srt:MinimumMember amot:AmendedRevolvingCreditFacilityMember 2020-01-01 2020-06-30 0000046129 srt:MaximumMember amot:AmendedRevolvingCreditFacilityMember 2020-01-01 2020-06-30 0000046129 amot:AmendedRevolvingCreditFacilityMember 2020-01-01 2020-06-30 0000046129 us-gaap:ForeignLineOfCreditMember 2020-01-01 2020-06-30 0000046129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000046129 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000046129 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0000046129 us-gaap:OtherLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000046129 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2020-04-01 2020-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2020-01-01 2020-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0000046129 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0000046129 amot:DynamicControlsMember us-gaap:TradeNamesMember 2020-03-07 2020-03-07 0000046129 amot:DynamicControlsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-03-07 2020-03-07 0000046129 amot:DynamicControlsMember us-gaap:CustomerListsMember 2020-03-07 2020-03-07 0000046129 srt:MinimumMember us-gaap:TradeNamesMember 2020-01-01 2020-06-30 0000046129 srt:MinimumMember us-gaap:CustomerListsMember 2020-01-01 2020-06-30 0000046129 srt:MinimumMember amot:DesignAndTechnologiesMember 2020-01-01 2020-06-30 0000046129 srt:MaximumMember us-gaap:TradeNamesMember 2020-01-01 2020-06-30 0000046129 srt:MaximumMember us-gaap:CustomerListsMember 2020-01-01 2020-06-30 0000046129 srt:MaximumMember amot:DesignAndTechnologiesMember 2020-01-01 2020-06-30 0000046129 us-gaap:PatentsMember 2020-01-01 2020-06-30 0000046129 us-gaap:TradeNamesMember 2020-06-30 0000046129 us-gaap:PatentsMember 2020-06-30 0000046129 us-gaap:CustomerListsMember 2020-06-30 0000046129 amot:DesignAndTechnologiesMember 2020-06-30 0000046129 us-gaap:TradeNamesMember 2019-12-31 0000046129 us-gaap:PatentsMember 2019-12-31 0000046129 us-gaap:CustomerListsMember 2019-12-31 0000046129 amot:DesignAndTechnologiesMember 2019-12-31 0000046129 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000046129 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000046129 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000046129 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000046129 us-gaap:InterestRateSwapMember 2020-01-01 2020-06-30 0000046129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0000046129 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000046129 amot:AmendedRevolvingCreditFacilityMember 2020-06-30 0000046129 us-gaap:RevolvingCreditFacilityMember 2020-06-30 0000046129 us-gaap:ForeignLineOfCreditMember 2020-06-30 0000046129 us-gaap:ForeignLineOfCreditMember 2019-12-31 0000046129 srt:MinimumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2020-01-01 2020-06-30 0000046129 srt:MinimumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-06-30 0000046129 srt:MaximumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2020-01-01 2020-06-30 0000046129 srt:MaximumMember amot:AmendedRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-06-30 0000046129 amot:AmendedRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2020-01-01 2020-06-30 0000046129 amot:AmendedRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-06-30 0000046129 us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0000046129 us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 0000046129 us-gaap:AccountsReceivableMember 2020-01-01 2020-06-30 0000046129 us-gaap:SalesRevenueNetMember 2019-04-01 2019-06-30 0000046129 us-gaap:AccountsReceivableMember 2019-01-01 2019-12-31 0000046129 us-gaap:SalesRevenueNetMember 2019-01-01 2019-06-30 0000046129 us-gaap:CommonStockMember 2020-06-30 0000046129 us-gaap:CommonStockMember 2020-03-31 0000046129 us-gaap:CommonStockMember 2019-12-31 0000046129 us-gaap:CommonStockMember 2019-06-30 0000046129 us-gaap:CommonStockMember 2019-03-31 0000046129 us-gaap:CommonStockMember 2018-12-31 0000046129 2019-06-30 0000046129 2018-12-31 0000046129 amot:DynamicControlsMember 2020-04-01 2020-06-30 0000046129 amot:DynamicControlsMember 2020-01-01 2020-06-30 0000046129 amot:ForeignSubsidiariesMember 2020-06-30 0000046129 amot:ForeignSubsidiariesMember 2019-12-31 0000046129 2020-08-01 0000046129 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000046129 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000046129 2020-01-01 2020-03-31 0000046129 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000046129 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000046129 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000046129 2019-01-01 2019-03-31 0000046129 us-gaap:RestrictedStockMember 2020-01-01 2020-06-30 0000046129 amot:DynamicControlsMember 2020-06-30 0000046129 amot:DynamicControlsMember 2020-03-07 0000046129 us-gaap:InterestRateSwapMember 2017-02-28 0000046129 srt:MinimumMember us-gaap:InterestRateSwapMember 2020-03-31 0000046129 us-gaap:InterestRateSwapMember 2020-03-31 0000046129 2020-04-01 2020-06-30 0000046129 2020-01-01 2020-06-30 0000046129 2019-04-01 2019-06-30 0000046129 2019-01-01 2019-06-30 0000046129 2020-06-30 0000046129 2019-12-31 iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares amot:derivative iso4217:CNY amot:segment

Table of Contents

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020.

OR

​

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________________to _________________________

Commission file number 0-04041

ALLIED MOTION TECHNOLOGIES INC.

(Exact name of Registrant as Specified in Its Charter)

​ | ​ | ​
Colorado |  | 84-0518115
(State or other jurisdiction of incorporation or organization) | ​ | (I.R.S. Employer Identification No.)
​ | ​ | ​
495 Commerce Drive, Amherst, New York (Address of principal executive offices) | ​ | 14228 (Zip Code)

​

(716) 242-8634

(Registrant’s Telephone Number, Including Area Code)

(Former Address, if Changed Since Last Report)

Title of each class |  | Trading Symbol |  | Name of each exchange on which registered
Common stock | ​ | AMOT | ​ | NASDAQ

​

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past ninety (90) days. Yes ⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ⌧ No ◻

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act.

​

Large accelerated filer ◻ | Accelerated filer ⌧ | Non-accelerated filer ◻ ​ | Smaller reporting company ☐ | Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ⌧

Number of Shares of the only class of Common Stock outstanding: 9,744,312 as of August 1, 2020

​

​

​

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

INDEX

​

PART I. FINANCIAL INFORMATION | Page No.
​ | ​ | ​
| Item 1. | Financial Statements |
​ | ​ | ​
| Condensed Consolidated Balance Sheets – Unaudited | 1
​ | ​ | ​
| Condensed Consolidated Statements of Income and Comprehensive Income – Unaudited | 2
​ | ​ | ​
| Condensed Consolidated Statements of Stockholders’ Equity – Unaudited | 3
​ | ​ | ​
| Condensed Consolidated Statements of Cash Flows – Unaudited | 4
​ | ​ | ​
| Notes to Condensed Consolidated Financial Statements - Unaudited | 5
​ | ​ | ​
| Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 19
​ | ​ | ​
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 26
​ | ​ | ​
| Item 4. | Controls and Procedures | 27
​ | ​
PART II. OTHER INFORMATION | 28
​ | ​ | ​
| Item 1A. | Risk Factors | 28
​ | ​ | ​
| Item 5. | Other Information | 28
​ | ​ | ​
| Item 6. | Exhibits | 29

​

​

​

​

Table of Contents

​

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31, | ​
​ |  | 2020 |  | 2019 |
Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and cash equivalents | ​ | $ | 19,019 | ​ | $ | 13,416 | ​
Trade receivables, net of provision for credit losses of $605 and allowance for doubtful accounts of $405 at June 30, 2020 and December 31, 2019, respectively | ​ | ​ | 49,595 | ​ | ​ | 44,429 | ​
Inventories | ​ |  | 61,453 | ​ |  | 53,385 | ​
Prepaid expenses and other assets | ​ |  | 3,699 | ​ |  | 4,413 | ​
Total current assets | ​ |  | 133,766 | ​ |  | 115,643 | ​
Property, plant and equipment, net | ​ |  | 53,465 | ​ |  | 53,008 | ​
Deferred income taxes | ​ |  | 846 | ​ |  | 490 | ​
Intangible assets, net | ​ |  | 67,378 | ​ |  | 62,497 | ​
Goodwill | ​ |  | 59,501 | ​ |  | 52,935 | ​
Right of use assets | ​ | ​ | 18,987 | ​ | ​ | 16,420 | ​
Other long-term assets | ​ |  | 4,556 | ​ |  | 4,835 | ​
Total Assets | ​ | $ | 338,499 | ​ | $ | 305,828 | ​
Liabilities and Stockholders’ Equity | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Accounts payable | ​ | $ | 27,453 | ​ | $ | 23,640 | ​
Accrued liabilities | ​ |  | 22,210 | ​ |  | 23,001 | ​
Total current liabilities | ​ |  | 49,663 | ​ |  | 46,641 | ​
Long-term debt | ​ |  | 128,452 | ​ |  | 109,765 | ​
Deferred income taxes | ​ |  | 4,649 | ​ |  | 3,399 | ​
Pension and post-retirement obligations | ​ |  | 5,205 | ​ |  | 5,139 | ​
Right of use liabilities | ​ | ​ | 15,471 | ​ | ​ | 13,715 | ​
Other long-term liabilities | ​ | ​ | 8,779 | ​ | ​ | 7,975 | ​
Total liabilities | ​ |  | 212,219 | ​ |  | 186,634 | ​
Stockholders’ Equity: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Common stock, no par value, authorized 50,000 shares; 9,744 and 9,599 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively | ​ |  | 39,786 | ​ |  | 37,136 | ​
Preferred stock, par value $1.00 per share, authorized 5,000 shares; no shares issued or outstanding | ​ |  | — | ​ |  | — | ​
Retained earnings | ​ |  | 98,938 | ​ |  | 92,589 | ​
Accumulated other comprehensive loss | ​ |  | (12,444) | ​ |  | (10,531) | ​
Total stockholders’ equity | ​ |  | 126,280 | ​ |  | 119,194 | ​
Total Liabilities and Stockholders’ Equity | ​ | $ | 338,499 | ​ | $ | 305,828 | ​

​

See accompanying notes to condensed consolidated financial statements.

​

1

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended | ​ | For the six months ended | ​
​ | ​ | June 30, | ​ | June 30, | ​
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019 |
Revenues | ​ | $ | 86,661 | ​ | $ | 92,630 | ​ | $ | 179,043 | ​ | $ | 186,526 | ​
Cost of goods sold | ​ |  | 60,201 | ​ |  | 64,208 | ​ |  | 124,541 | ​ |  | 130,442 | ​
Gross profit | ​ |  | 26,460 | ​ |  | 28,422 | ​ |  | 54,502 | ​ |  | 56,084 | ​
Operating costs and expenses: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Selling | ​ |  | 3,842 | ​ |  | 4,136 | ​ |  | 8,085 | ​ |  | 8,229 | ​
General and administrative | ​ |  | 9,710 | ​ |  | 9,569 | ​ |  | 18,872 | ​ |  | 18,519 | ​
Engineering and development | ​ |  | 6,197 | ​ |  | 5,676 | ​ |  | 12,431 | ​ |  | 11,483 | ​
Business development | ​ |  | 177 | ​ |  | 3 | ​ |  | 424 | ​ |  | 56 | ​
Amortization of intangible assets | ​ |  | 1,483 | ​ |  | 1,430 | ​ |  | 2,924 | ​ |  | 2,862 | ​
Total operating costs and expenses | ​ |  | 21,409 | ​ |  | 20,814 | ​ |  | 42,736 | ​ |  | 41,149 | ​
Operating income | ​ |  | 5,051 | ​ |  | 7,608 | ​ |  | 11,766 | ​ |  | 14,935 | ​
Other expense (income): | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest expense | ​ |  | 901 | ​ |  | 1,435 | ​ |  | 1,955 | ​ |  | 2,615 | ​
Other expense (income), net | ​ |  | 17 | ​ |  | (1) | ​ |  | 76 | ​ |  | (19) | ​
Total other expense, net | ​ |  | 918 | ​ |  | 1,434 | ​ |  | 2,031 | ​ |  | 2,596 | ​
Income before income taxes | ​ |  | 4,133 | ​ |  | 6,174 | ​ |  | 9,735 | ​ |  | 12,339 | ​
Provision for income taxes | ​ |  | (1,237) | ​ |  | (1,729) | ​ |  | (2,804) | ​ |  | (3,424) | ​
Net income | ​ | $ | 2,896 | ​ | $ | 4,445 | ​ | $ | 6,931 | ​ | $ | 8,915 | ​
Basic earnings per share: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share | ​ | $ | 0.30 | ​ | $ | 0.47 | ​ | $ | 0.73 | ​ | $ | 0.95 | ​
Basic weighted average common shares | ​ |  | 9,509 | ​ |  | 9,408 | ​ |  | 9,474 | ​ |  | 9,378 | ​
Diluted earnings per share: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share | ​ | $ | 0.30 | ​ | $ | 0.47 | ​ | $ | 0.73 | ​ | $ | 0.95 | ​
Diluted weighted average common shares | ​ |  | 9,536 | ​ |  | 9,456 | ​ |  | 9,518 | ​ |  | 9,419 | ​
Net income | ​ | $ | 2,896 | ​ | $ | 4,445 | ​ | $ | 6,931 | ​ | $ | 8,915 | ​
Foreign currency translation adjustment | ​ | ​ | 1,932 | ​ | ​ | 548 | ​ | ​ | (496) | ​ | ​ | (339) | ​
Loss on derivatives | ​ | ​ | (329) | ​ | ​ | (436) | ​ | ​ | (1,417) | ​ | ​ | (698) | ​
Comprehensive income | ​ | $ | 4,499 | ​ | $ | 4,557 | ​ | $ | 5,018 | ​ | $ | 7,878 | ​

​

See accompanying notes to condensed consolidated financial statements.

​

2

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except per share data)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Common Stock |  | ​ | ​ | ​ | ​ |  | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | Unamortized | ​ | Common Stock | ​ | ​ | ​ | Other | ​ | Total
​ | ​ | ​ | ​ | ​ | ​ | Cost of Equity | ​ | and Paid-in | ​ | Retained | ​ | Comprehensive | ​ | Stockholders'
(In thousands except per share data) |  | Shares |  | Amount |  | Awards |  | Capital |  | Earnings |  | Loss |  | Equity
Balances, December 31, 2019 |  | 9,599 | ​ | $ | 41,642 | ​ | $ | (4,506) | ​ | $ | 37,136 | ​ | $ | 92,589 | ​ | $ | (10,531) | ​ | $ | 119,194
Stock transactions under employee benefit stock plans |  | 32 | ​ |  | 1,252 | ​ | ​ | ​ | ​ | ​ | 1,252 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 1,252
Issuance of restricted stock, net of forfeitures |  | 104 | ​ |  | 3,574 | ​ |  | (3,089) | ​ | ​ | 485 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 485
Stock compensation expense | ​ | ​ | ​ | ​ | ​ | ​ |  | 789 | ​ | ​ | 789 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 789
Shares withheld for payment of employee payroll taxes | ​ | (24) | ​ | ​ | (256) | ​ | ​ | ​ | ​ | ​ | (256) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (256)
Foreign currency translation adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (2,428) | ​ | ​ | (2,428)
Accumulated income (loss) on derivatives | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (1,432) | ​ | ​ | (1,432)
Tax effect of derivative transactions | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 344 | ​ | ​ | 344
Net income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 4,035 | ​ | ​ | ​ | ​ |  | 4,035
Dividends to stockholders - $0.03 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (290) | ​ | ​ | ​ | ​ | ​ | (290)
Balances, March 31, 2020 |  | 9,711 | ​ | ​ | 46,212 | ​ | ​ | (6,806) | ​ | ​ | 39,406 | ​ | ​ | 96,334 | ​ | ​ | (14,047) | ​ | ​ | 121,693
Issuance of restricted stock, net of forfeitures |  | 38 | ​ |  | 1,222 | ​ |  | (1,222) | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | —
Stock compensation expense | ​ | ​ | ​ | ​ | ​ | ​ |  | 921 | ​ | ​ | 921 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 921
Shares withheld for payment of employee payroll taxes | ​ | (5) | ​ | ​ | (541) | ​ | ​ | ​ | ​ | ​ | (541) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (541)
Foreign currency translation adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 1,932 | ​ | ​ | 1,932
Accumulated income (loss) on derivatives | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (433) | ​ | ​ | (433)
Tax effect of derivative transactions | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 104 | ​ | ​ | 104
Net income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 2,896 | ​ | ​ | ​ | ​ |  | 2,896
Dividends to stockholders - $0.03 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (292) | ​ | ​ | ​ | ​ | ​ | (292)
Balances, June 30, 2020 |  | 9,744 | ​ | $ | 46,893 | ​ | $ | (7,107) | ​ | $ | 39,786 | ​ | $ | 98,938 | ​ | $ | (12,444) | ​ | $ | 126,280

​

​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common Stock | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | Unamortized | ​ | Common Stock | ​ | ​ | ​ | Other | ​ | Total
​ | ​ | ​ | ​ | ​ | ​ | Cost of Equity | ​ | and Paid-in | ​ | Retained | ​ | Comprehensive | ​ | Stockholders'
​ |  | Shares |  | Amount |  | Awards |  | Capital |  | Earnings |  | Loss |  | Equity
Balances, December 31, 2018 | ​ | 9,485 | ​ | $ | 36,779 | ​ | $ | (3,166) | ​ | $ | 33,613 | ​ | $ | 76,718 | ​ | $ | (8,518) | ​ | $ | 101,813
Stock transactions under employee benefit stock plans |  | 27 | ​ |  | 1,088 | ​ | ​ | ​ | ​ | ​ | 1,088 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 1,088
Issuance of restricted stock, net of forfeitures |  | 96 | ​ |  | 4,059 | ​ |  | (3,729) | ​ | ​ | 330 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 330
Stock compensation expense | ​ | ​ | ​ | ​ | ​ | ​ |  | 596 | ​ | ​ | 596 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 596
Shares withheld for payment of employee payroll taxes | ​ | (1) | ​ | ​ | (63) | ​ | ​ | ​ | ​ | ​ | (63) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (63)
Foreign currency translation adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (887) | ​ | ​ | (887)
Accumulated income (loss) on derivatives | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (343) | ​ | ​ | (343)
Tax effect of derivative transactions | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 81 | ​ | ​ | 81
Net income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 4,470 | ​ | ​ | ​ | ​ |  | 4,470
Dividends to stockholders - $0.03 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (287) | ​ | ​ | ​ | ​ | ​ | (287)
Balances, March 31, 2019 |  | 9,607 | ​ | $ | 41,863 | ​ | $ | (6,299) | ​ | $ | 35,564 | ​ | $ | 80,901 | ​ | $ | (9,667) | ​ | $ | 106,798
Issuance of restricted stock, net of forfeitures |  | 11 | ​ |  | 416 | ​ |  | (416) | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | —
Stock compensation expense | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 780 | ​ | ​ | 780 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 780
Shares withheld for payment of employee payroll taxes | ​ | (18) | ​ | ​ | (647) | ​ | ​ | ​ | ​ | ​ | (647) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (647)
Foreign currency translation adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 548 | ​ | ​ | 548
Accumulated income (loss) on derivatives | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (564) | ​ | ​ | (564)
Tax effect of derivative transactions | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 128 | ​ | ​ | 128
Net income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 4,445 | ​ | ​ | ​ | ​ |  | 4,445
Dividends to stockholders - $0.03 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (288) | ​ | ​ | ​ | ​ | ​ | (288)
Balances, June 30, 2019 |  | 9,600 | ​ | $ | 41,632 | ​ | $ | (5,935) | ​ | $ | 35,697 | ​ | $ | 85,058 | ​ | $ | (9,555) | ​ | $ | 111,200

​

See accompanying notes to condensed consolidated financial statements.

​

3

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the six months ended | ​
​ | ​ | June 30, | ​
​ |  | 2020 |  | 2019 |
Cash Flows From Operating Activities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 6,931 | ​ | $ | 8,915 | ​
Adjustments to reconcile net income to net cash provided by operating activities | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ |  | 7,627 | ​ |  | 7,327 | ​
Deferred income taxes | ​ |  | (841) | ​ |  | (491) | ​
Stock based compensation expense | ​ | ​ | 1,720 | ​ | ​ | 1,540 | ​
Debt issue cost amortization recorded in interest expense | ​ | ​ | 73 | ​ | ​ | 87 | ​
Other | ​ |  | 885 | ​ |  | (166) | ​
Changes in operating assets and liabilities, net of acquisition: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Trade receivables | ​ |  | (1,178) | ​ |  | (8,692) | ​
Inventories | ​ |  | (5,193) | ​ |  | 1,973 | ​
Prepaid expenses and other assets | ​ |  | 1,472 | ​ |  | (289) | ​
Accounts payable | ​ |  | (1,627) | ​ |  | (795) | ​
Accrued liabilities | ​ |  | (3,270) | ​ |  | (557) | ​
Net cash provided by operating activities | ​ |  | 6,599 | ​ |  | 8,852 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows From Investing Activities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Purchase of property and equipment | ​ | ​ | (3,614) | ​ | ​ | (6,401) | ​
Cash paid for acquisitions, net of cash acquired | ​ | ​ | (14,728) | ​ | ​ | — | ​
Net cash used in investing activities | ​ |  | (18,342) | ​ |  | (6,401) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows From Financing Activities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Borrowings on long term debt | ​ | ​ | 26,979 | ​ | ​ | 7,695 | ​
Principal payments of long-term debt | ​ | ​ | (7,937) | ​ | ​ | (7,000) | ​
Payment of debt issuance costs | ​ |  | (401) | ​ |  | — | ​
Dividends paid to stockholders | ​ |  | (569) | ​ |  | (605) | ​
Stock transactions under employee benefit stock plans | ​ |  | (797) | ​ |  | (710) | ​
Net cash provided by (used in) financing activities | ​ |  | 17,275 | ​ |  | (620) | ​
Effect of foreign exchange rate changes on cash | ​ |  | 71 | ​ |  | (41) | ​
Net increase in cash and cash equivalents | ​ |  | 5,603 | ​ |  | 1,790 | ​
Cash and cash equivalents at beginning of period | ​ |  | 13,416 | ​ |  | 8,673 | ​
Cash and cash equivalents at end of period | ​ | $ | 19,019 | ​ | $ | 10,463 | ​

​

See accompanying notes to condensed consolidated financial statements.

​

​

4

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

1. BASIS OF PREPARATION AND PRESENTATION

Allied Motion Technologies Inc. (“Allied Motion” or the “Company”) is engaged in the business of designing, manufacturing and selling controlled motion solutions, which include integrated system solutions as well as individual controlled motion products, to a broad spectrum of customers throughout the world. The Company’s target markets include Vehicle, Medical, Aerospace & Defense and Industrial.

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars using end of period exchange rates. Changes in reported amounts of assets and liabilities of foreign subsidiaries that occur as a result of changes in exchange rates between foreign subsidiaries’ functional currencies and the U.S. dollar are included in foreign currency translation adjustment. Foreign currency translation adjustment is included in other comprehensive loss, a component of stockholders’ equity in the accompanying condensed consolidated statements of stockholders’ equity. Revenue and expense transactions use an average rate prevailing during the month of the related transaction. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency of each of the Technology Units (“TUs”) are included in the results of operations as incurred.

The condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and include all adjustments which are, in the opinion of management, necessary for a fair presentation. Certain information and footnote disclosures normally included in financial statements which are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures herein are adequate to make the information presented not misleading. The financial data for the interim periods may not necessarily be indicative of results to be expected for the year.

The preparation of financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities as well as disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.

It is suggested that the accompanying condensed consolidated financial statements be read in conjunction with the Consolidated Financial Statements and related Notes to such statements included in the Annual Report on Form 10-K for the year ended December 31, 2019 that was previously filed by the Company.

​

2. ACQUISITIONS

Dynamic Controls

On March 7, 2020, the Company acquired 100% of the issued and outstanding share capital of the Dynamic Controls Group (“Dynamic Controls”), a wholly owned subsidiary of Invacare Corporation, a market-leading designer and manufacturer of equipment for the medical mobility and rehabilitation markets. The purchase price was funded using borrowings under the Amended Revolving Facility (Note 10). The purchase price was subject to adjustments based on a determination of closing net working capital.

Dynamic Controls brings strong leadership and a very experienced electronics and software engineering design team, providing market leading electronic control solutions and products that will further strengthen the Company’s medical market position, as well as enable it to further develop higher level solutions with embedded electronics across our other major served markets.

The Company incurred $177 and $424 of transaction costs related to the acquisition of Dynamic Controls in the three and six months ended June 30, 2020, which are included in business development expenses on the condensed consolidated statements of income and

5

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

comprehensive income. The Company accounted for the acquisition pursuant to the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805, “Business Combinations.”

The preliminary allocation of the purchase price paid for Dynamic Controls is based on estimated fair values of the assets acquired and liabilities assumed of Dynamic Controls as of March 7, 2020 is as follows (in thousands):

​

​ | ​ | ​ | ​
Cash and cash equivalents |  | $ | 11,437
Accounts receivable | ​ | ​ | 4,129
Inventory | ​ | ​ | 3,329
Other assets, net | ​ |  | 769
Property, plant and equipment | ​ |  | 1,185
Right of use assets | ​ | ​ | 2,735
Intangible assets | ​ | ​ | 7,800
Goodwill | ​ |  | 6,552
Current liabilities | ​ | ​ | (7,277)
Lease liabilities | ​ | ​ | (2,739)
Net deferred income tax liabilities | ​ | ​ | (1,755)
Net purchase price | ​ | $ | 26,165

​

During the three months ended June 30, 2020, measurement period adjustments primarily related to deferred income taxes and the true-up of closing net working capital were recognized, which resulted in a reduction of goodwill by $268. The allocation of the purchase price is preliminary as the valuation of both the tangible and identifiable intangible assets and liabilities is being finalized.

The intangible assets acquired consist of customer lists, technology and a trade name, which are being amortized over 16, 13 and 18 years, respectively. Goodwill generated in the acquisition is related to the assembled workforce, synergies between Allied Motion’s other operations and Dynamic Controls that are expected to occur as a result of the combined engineering knowledge, the ability of each of the operations to integrate each other’s products into more fully integrated system solutions and Allied Motion’s ability to utilize Dynamic Controls’ management knowledge in providing complementary product offerings to the Company’s customers.

The operating results of this acquisition are included in our condensed consolidated financial statements beginning on the date of the acquisition. Included within the condensed consolidated statements of income and comprehensive income for the three and six months ended June 30, 2020, revenues related to Dynamic Controls were $9,913 and $12,415 respectively, and earnings related to the operations of Dynamic Controls were $1,048 and $1,172 respectively. Unaudited pro forma revenues, assuming the acquisition occurred on January 1, 2019, would have been $99,997 for the three months ended June 30, 2019 and $184,205 and $201,914 for the six months ended June 30, 2020 and 2019, respectively. Pro forma earnings and diluted earnings per share would have been $734, or $0.08 per share, lower than actual reported results in the three months ended June 30, 2019 and $956, or $0.10 per share, lower than actual reported results in the six months ended June 30, 2019. Pro forma earnings and diluted earnings per share for the six months ended June 30, 2020 would have been $654, or $0.07 per share, higher than actual reported results. The pro forma information includes certain adjustments, including depreciation and amortization expense, interest expense, and certain other adjustments, together with related income tax effects. The pro forma amounts do not reflect adjustments for anticipated operating efficiencies that the Company expects to achieve as a result of this acquisition. The pro forma financial information is for informational purposes only and does not purport to present what the Company’s results would have been had these transactions actually occurred on the date presented or to project the combined company’s results of operations or financial position for any future period.

The goodwill resulting from the Dynamic Controls acquisition is not tax deductible.

​

6

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

3. REVENUE RECOGNITION

Performance Obligations

Performance Obligations Satisfied at a Point in Time

The Company considers control of most products to transfer at a single point in time when control is transferred to the customer, generally when the products are shipped in accordance with an agreement and/or purchase order. Control is defined as the ability to direct the use of and obtain substantially all of the remaining benefits of the product.

The Company satisfies its performance obligations under a contract with a customer by transferring goods and services in exchange for monetary consideration from the customer. The Company considers the customer’s purchase order, and the Company’s corresponding sales order acknowledgment as the contract with the customer. For some customers, control, and a sale, is transferred at a point in time when the product is delivered to a customer.

Sales, value add, and other taxes we collect concurrent with revenue-producing activities are excluded from revenue.

Nature of Goods and Services

The Company sells component and integrated controlled motion solutions to end customers and original equipment manufacturers (“OEM’s”) through the Company’s own direct sales force and authorized manufacturers’ representatives and distributors. The Company’s products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products. The Company’s target markets include Vehicle, Medical, Aerospace & Defense and Industrial.

Determining the Transaction Price

The majority of the Company’s contracts have an original duration of less than one year. For these contracts, the Company applies the practical expedient and therefore does not consider the effects of the time value of money. For multiyear contracts, the Company uses judgment to determine whether there is a significant financing component. These contracts are generally those in which the customer has made an up-front payment. Contracts that management determines to include a significant financing component are discounted at the Company’s incremental borrowing rate. The Company incurs interest expense and accrues a contract liability. As the Company satisfies performance obligations and recognizes revenue from these contracts, interest expense is recognized simultaneously. Management does not have any contracts that include a significant financing component as of June 30, 2020.

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers into geographical regions and target markets. The Company determines that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. As noted in the Segment Information footnote, the Company’s business consists of one reportable segment. The foreign revenues by geography in the table below are revenues derived from the Company's foreign subsidiaries as provided in Note 18.

​

7

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

A reconciliation of disaggregated revenue to segment revenue as well as revenue by geographical regions is provided in Note 18 (in thousands).

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​ | Six months ended | ​
​ | ​ | June 30, | ​ | June 30, | ​
Target Market |  | 2020 |  | 2019 |  | 2020 |  | 2019 | ​
Vehicle | ​ | $ | 18,584 | ​ | $ | 30,778 | ​ | $ | 46,639 | ​ | $ | 64,374 | ​
Industrial | ​ |  | 28,223 | ​ |  | 32,194 | ​ |  | 61,574 | ​ |  | 63,505 | ​
Medical | ​ |  | 24,261 | ​ |  | 12,219 | ​ |  | 38,812 | ​ |  | 24,629 | ​
Aerospace & Defense | ​ |  | 10,516 | ​ |  | 12,143 | ​ |  | 21,658 | ​ |  | 23,397 | ​
Other | ​ |  | 5,077 | ​ |  | 5,296 | ​ |  | 10,360 | ​ |  | 10,621 | ​
Total | ​ | $ | 86,661 | ​ | $ | 92,630 | ​ | $ | 179,043 | ​ | $ | 186,526 | ​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​ | Six months ended | ​
​ | ​ | June 30, | ​ | June 30, | ​
Geography |  | 2020 |  | 2019 |  | 2020 |  | 2019 | ​
United States | ​ | $ | 47,311 | ​ | $ | 62,645 | ​ | $ | 103,680 | ​ | $ | 121,957 | ​
Europe | ​ |  | 29,012 | ​ |  | 29,390 | ​ |  | 62,145 | ​ |  | 63,561 | ​
Other | ​ |  | 10,338 | ​ |  | 595 | ​ |  | 13,218 | ​ |  | 1,008 | ​
Total | ​ | $ | 86,661 | ​ | $ | 92,630 | ​ | $ | 179,043 | ​ | $ | 186,526 | ​

​

Contract Balances

When the timing of the Company’s delivery of product is different from the timing of the payments made by customers, the Company recognizes either a contract asset (performance precedes customer payment) or a contract liability (customer payment precedes performance). Typically, contracts are paid in arrears and are recognized as receivables after the Company considers whether a significant financing component exists.

The opening and closing balances of the Company’s contract liabilities are as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, |  | December 31,
​ | ​ | 2020 | ​ | 2019
Contract liabilities in accrued liabilities | ​ | $ | 344 | ​ | $ | 454
Contract liabilities in other long-term liabilities | ​ | ​ | 284 | ​ | ​ | —
​ | ​ | $ | 628 | ​ | $ | 454

​

The difference between the opening and closing balances of the Company’s contract liabilities primarily results from the timing difference between the Company’s performance and the customer’s payment.

Significant Payment Terms

The Company’s contracts with its customers state the final terms of the sale, including the description, quantity, and price of each product or service purchased. Payments are typically due in full within 30-60 days of delivery. Since the customer agrees to a stated rate and price in the contract that do not vary over the contract, the majority of contracts do not contain variable consideration.

Returns, Refunds, and Warranties

In the normal course of business, the Company does not accept product returns unless the item is defective as manufactured. The Company establishes provisions for estimated returns and warranties. All contracts include a standard warranty clause to guarantee that the product complies with agreed specifications.

8

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

4. INVENTORIES

Inventories include costs of materials, direct labor and manufacturing overhead, and are stated at the lower of cost (first-in, first-out basis) or net realizable value, as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, |  | December 31, | ​
​ | ​ | 2020 | ​ | 2019 | ​
Parts and raw materials | ​ | $ | 42,886 | ​ | $ | 35,849 | ​
Work-in-process | ​ |  | 7,107 | ​ |  | 6,951 | ​
Finished goods | ​ |  | 11,460 | ​ |  | 10,585 | ​
​ | ​ | ​ | 61,453 | ​ | ​ | 53,385 | ​

​

​

5. PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment is classified as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, |  | December 31,
​ | ​ | 2020 | ​ | 2019
Land | ​ | $ | 976 | ​ | $ | 977
Building and improvements |  |  | 13,604 | ​ |  | 13,366
Machinery, equipment, tools and dies |  |  | 77,565 | ​ |  | 73,894
Furniture, fixtures and other |  |  | 16,832 | ​ |  | 15,797
​ | ​ |  | 108,977 | ​ |  | 104,034
Less accumulated depreciation | ​ |  | (55,512) | ​ |  | (51,026)
Property, plant and equipment, net | ​ | $ | 53,465 | ​ | $ | 53,008

​

Depreciation expense was approximately $2,394 and $2,238 for the quarters ended June 30, 2020 and 2019, respectively. For the six months ended June 30, 2020 and 2019, depreciation expense was $4,703 and $4,465, respectively.

​

6. GOODWILL

The change in the carrying amount of goodwill for the six months ended is as follows (in thousands):

​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​
Beginning balance | ​ | $ | 52,935 | ​
Goodwill acquired (Note 2) | ​ |  | 6,552 | ​
Effect of foreign currency translation | ​ |  | 14 | ​
Ending balance | ​ | $ | 59,501 | ​

​

​

7. INTANGIBLE ASSETS

Intangible assets on the Company’s condensed consolidated balance sheets consist of the following (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | June 30, 2020 | ​ | December 31, 2019
​ |  | ​ |  | Gross |  | Accumulated |  | Net Book |  | Gross |  | Accumulated |  | Net Book
​ | ​ | Life | ​ | Amount | ​ | amortization | ​ | Value | ​ | Amount | ​ | amortization | ​ | Value
Customer lists |  | 8 - 17 years | ​ | $ | 68,698 | ​ | $ | (21,315) | ​ | $ | 47,383 | ​ | $ | 64,314 | ​ | $ | (19,311) | ​ | $ | 45,003
Trade name |  | 10 - 19 years | ​ |  | 13,733 | ​ |  | (4,549) | ​ |  | 9,184 | ​ |  | 12,222 | ​ |  | (4,114) | ​ |  | 8,108
Design and technologies |  | 10 - 15 years | ​ |  | 14,836 | ​ |  | (4,037) | ​ |  | 10,799 | ​ |  | 12,927 | ​ |  | (3,554) | ​ |  | 9,373
Patents | ​ | 17 years | ​ |  | 24 | ​ |  | (12) | ​ |  | 12 | ​ |  | 24 | ​ |  | (11) | ​ |  | 13
Total | ​ | ​ | ​ | $ | 97,291 | ​ | $ | (29,913) | ​ | $ | 67,378 | ​ | $ | 89,487 | ​ | $ | (26,990) | ​ | $ | 62,497

​

Intangible assets resulting from the acquisition of Dynamic Controls were $7,800 (Note 2). The intangible assets acquired consist of a customer list, a trade name and technology.

9

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

Amortization expense for intangible assets was $1,483 and $1,430 for the quarters ended June 30, 2020 and 2019, respectively. For the six months ended June 30, 2020 and 2019, amortization expense was $2,924 and $2,862, respectively.

Estimated future intangible asset amortization expense as of June 30, 2020 is as follows (in thousands):

​

​ | ​ | ​ | ​
​ | ​ | Estimated
​ |  | Amortization Expense
Remainder of 2020 | ​ | $ | 2,976
2021 | ​ |  | 5,945
2022 | ​ |  | 5,990
2023 | ​ | ​ | 5,996
2024 | ​ |  | 5,670
Thereafter | ​ |  | 40,801
Total estimated amortization expense | ​ | $ | 67,378

​

​

​

8. STOCK-BASED COMPENSATION

Stock Incentive Plans

The Company’s Stock Incentive Plans provide for the granting of stock awards, including restricted stock, stock options and stock appreciation rights, to employees and non-employees, including directors of the Company.

Restricted Stock

For the quarter ended June 30, 2020, 146,437 shares of unvested restricted stock were awarded at a weighted average market value of $32.92. Of the restricted shares granted, 100,403 shares have performance-based vesting conditions. The value of the shares is amortized to compensation expense over the related service period, which is normally three years, or over the estimated performance period. Shares of unvested restricted stock are generally forfeited if a recipient leaves the Company before the vesting date. Shares that are forfeited become available for future awards.

The following is a summary of restricted stock activity for the six-months ended June 30, 2020:

​

​ | ​ | ​
​ | ​ | Number of
​ |  | shares
Outstanding at beginning of period |  | 186,702
Awarded |  | 146,437
Vested |  | (88,128)
Forfeited |  | (1,811)
Outstanding at end of period |  | 243,200

​

Stock based compensation expense, net of forfeitures, of $931 and $866 was recorded for the quarters ended June 30, 2020 and 2019, respectively. For the six months ended June 30, 2020 and 2019, Stock based compensation expense, net of forfeitures, of $1,720 and $1,540 was recorded, respectively.

​

10

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

9. ACCRUED LIABILITIES

Accrued liabilities consist of the following (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2020 |  | 2019
Compensation and fringe benefits | ​ | $ | 9,588 | ​ | $ | 12,967
Warranty reserve | ​ |  | 1,508 | ​ |  | 1,075
Income taxes payable | ​ | ​ | 2,852 | ​ | ​ | 2,231
Right of use liabilities | ​ | ​ | 4,016 | ​ | ​ | 3,203
Other accrued expenses | ​ |  | 4,246 | ​ |  | 3,525
​ | ​ | $ | 22,210 | ​ | $ | 23,001

​

​

​

​

10. DEBT OBLIGATIONS

Debt obligations consisted of the following (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2020 |  | 2019
Long-term Debt | ​ | ​ | ​ | ​ | ​ | ​
Revolving Credit Facility, long-term (1) | ​ | $ | 129,099 | ​ | $ | 110,085
Unamortized debt issuance costs | ​ | ​ | (647) | ​ | ​ | (320)
Long-term debt | ​ | $ | 128,452 | ​ | $ | 109,765

| (1) | The effective rate of the Revolver is 2.34% at June 30, 2020.

Amended Revolving Credit Facility

On February 12, 2020, the Company entered into a First Amended and Restated Credit Agreement (the “Amended Credit Agreement”) for a $225 million revolving credit facility (the “Amended Revolving Facility”). The significant changes made to the Company’s prior credit facility by the Amended Credit Agreement include (i) increasing the maximum principal amount from $175 million to $225 million, (ii) providing for a $75 million accordion amount, (iii) decreasing certain interest-rate margins and fees, and (iv) extending the term to February 2025 from the original term of October 2021. HSBC Bank USA, National Association is the administrative agent, and HSBC Securities (USA) Inc., KeyBank N.A, Wells Fargo Bank, N.A and Citizens Bank, N.A. are joint lead arrangers.

Borrowings under the Amended Revolving Facility bear interest at the LIBOR Rate (as defined in the Amended Credit Agreement) plus a margin of 1.00% to 1.75% or the Prime Rate (as defined in the Amended Credit Agreement) plus a margin of 0% to 0.75%, in each case depending on the Company’s ratio of total funded indebtedness (as defined in the Amended Credit Agreement) to Consolidated trailing twelve-month EBITDA (the “Total Leverage Ratio”). At June 30, 2020, the applicable margin for LIBOR Rate borrowings was 1.5% and the applicable margin for Prime Rate borrowings was 0.5%. In addition, the Company is required to pay a commitment fee of between 0.10% and 0.225% quarterly (currently 0.175%) on the unused portion of the Amended Revolving Facility, also based on the Company’s Total Leverage Ratio. The Amended Revolving Facility is secured by substantially all of the Company’s non-realty assets and is fully and unconditionally guaranteed by certain of the Company’s subsidiaries.

The Amended Credit Agreement contains certain financial covenants related to minimum interest coverage and total leverage ratio at the end of each quarter. The Amended Credit Agreement also includes other covenants and restrictions, including limits on the amount of additional indebtedness, and restrictions on the Company’s ability to merge or sell all or substantially all of its assets. The Company was in compliance with all covenants at June 30, 2020.

As of June 30, 2020, the unused Amended Revolving Facility was $95,901. The amount available to borrow may be reduced based upon our debt and EBITDA levels, which impacts our covenant calculations.

11

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

Other

The China Credit Facility provides credit of $1,414 (Chinese Renminbi 10,000) (“the China Facility”). The China Facility is a demand revolving facility used for working capital and capital equipment needs at the Company’s China operations. The term is annual and may be cancelled at the bank’s discretion. The interest rate is 110% of the applicable PBOC Benchmark Lending Rate. Collateral for the facility is a guarantee issued by the Company. There have been no borrowings during 2020 and there is no balance in the China Facility at June 30, 2020 and December 31, 2019.

​

​

11. DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, and foreign exchange risk primarily through the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash payments principally related to the Company’s borrowings.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In February 2017, the Company entered into three interest rate swaps with a combined notional amount of $40,000 that mature in February 2022. In March 2020, the Company entered into two additional interest rate swaps with a combined notional amount of $20,000 that increases to $60,000 in March 2022 and matures in December 2024.

The changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in Accumulated Other Comprehensive Income (Loss) and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During 2020 and 2019, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.

The Company estimates that an additional $891 will be reclassified as an increase to interest expense over the next twelve months. Additionally, the Company does not use derivatives for trading or speculative purposes and currently does not have any derivatives that are not designated as hedges.

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of June 30, 2020 and December 31, 2019 (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Asset Derivatives | ​ | ​ | ​ | Liability Derivatives | ​
​ | ​ | ​ | ​ | Fair value as of: | ​ | ​ | ​ | Fair value as of: | ​
Derivatives designated as | ​ | Balance Sheet | ​ | June 30, | ​ | December 31, | ​ | Balance Sheet | ​ | June 30, | ​ | December 31, | ​
hedging instruments |  | Location |  | 2020 |  | 2019 |  | Location |  | 2020 |  | 2019 |
Interest rate products | ​ | Other long-term assets | ​ | $ | — | ​ | $ | — | ​ | Other long-term liabilities | ​ | $ | 2,228 | ​ | $ | 363 | ​

​

The tables below present the effect of cash flow hedge accounting on other comprehensive income (loss) (“OCI”) for the three and six months ended June 30, 2020 and 2019 (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of gain (loss) recognized in OCI | ​ | Amount of gain (loss) recognized in OCI | ​
​ | ​ | on derivatives | ​ | on derivative | ​
Derivatives in cash flow hedging relationships | ​ | Three months ended June 30, | ​ | Six months ended June 30, | ​
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019 |
Interest rate products | ​ | $ | (448) | ​ | $ | (387) | ​ | $ | (1,560) | ​ | $ | (597) | ​

​

12

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of gain (loss) reclassified from | ​ | Amount of gain (loss) reclassified from | ​
​ | ​ | accumulated OCI into income | ​ | accumulated OCI into income | ​
Location of (gain) loss reclassified | ​ | Three months ended June 30, | ​ | Six months ended June 30, | ​
from accumulated OCI into income | ​ | 2020 | ​ | 2019 |  | 2020 |  | 2019 | ​
Interest income (expense) | ​ | $ | (155) | ​ | $ | 49 | ​ | $ | (186) | ​ | $ | 101 | ​

​

The table below presents the effect of the Company’s derivative financial instruments on the condensed consolidated statements of income and comprehensive income for the three and six months ended June 30, 2020 and 2019 (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Total amounts of income and expense | ​ | Total amounts of income and expense | ​
​ | ​ | ​ | ​ | line items presented that reflect the | ​ | line items presented that reflect the | ​
​ | ​ | ​ | ​ | effects of cash flow hedges recorded | ​ | effects of cash flow hedges recorded | ​
​ | ​ | ​ | ​ | Three months ended June 30, | ​ | Six months ended June 30, | ​
Derivatives designated as hedging instruments |  | Income Statement Location |  | 2020 |  | 2019 |  | 2020 |  | 2019 |
Interest rate products |  | Interest Expense | ​ | $ | 901 | ​ | $ | 1,435 | ​ | $ | 1,955 | ​ | $ | 2,615 | ​

​

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of June 30, 2020 and December 31, 2019. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented in the condensed consolidated balance sheets (in thousands).

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Gross amounts | ​ | Net amounts of liabilities | ​ | Gross amounts not offset in the condensed consolidated
As of | ​ | Gross amounts | ​ | offset in the | ​ | presented in the | ​ | balance sheets
June 30, | ​ | of recognized | ​ | condensed consolidated | ​ | condensed consolidated | ​ | Financial | ​ | Cash collateral | ​ | ​ | ​
2020 |  | liabilities |  | balance sheets |  | balance sheets |  | instruments |  | received |  | Net amount
Derivatives | ​ | $ | 2,228 | ​ | $ | — | ​ | $ | 2,228 | ​ | $ | — | ​ | $ | — | ​ | $ | 2,228

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Gross amounts | ​ | Net amounts of liabilities | ​ | Gross amounts not offset in the condensed consolidated
As of | ​ | Gross amounts | ​ | offset in the | ​ | presented in the | ​ | balance sheets
December 31, | ​ | of recognized | ​ | condensed consolidated | ​ | condensed consolidated | ​ | Financial | ​ | Cash collateral | ​ | ​ | ​
2019 |  | liabilities |  | balance sheets |  | balance sheets |  | instruments |  | received |  | Net amount
Derivatives | ​ | $ | 363 | ​ | $ | — | ​ | $ | 363 | ​ | $ | — | ​ | $ | — | ​ | $ | 363

​

The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations.

​

12. FAIR VALUE

Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.

The guidance establishes a framework for measuring fair value which utilizes observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. Preference is given to observable inputs.

These two types of inputs create the following three - level fair value hierarchy:

Level 1: | Quoted prices for identical assets or liabilities in active markets.
Level 2: | Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model - derived valuations whose inputs or significant value drivers are observable.
Level 3: | Significant inputs to the valuation model that are unobservable.

13

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

The Company’s financial assets and liabilities include cash and cash equivalents, accounts receivable, debt obligations, accounts payable, and accrued liabilities. The carrying amounts reported in the condensed consolidated balance sheets for these assets approximate fair value because of the immediate or short-term maturities of these financial instruments.

The following tables presents the Company’s financial assets that are accounted for at fair value on a recurring basis as of June 30, 2020 and December 31, 2019, respectively, by level within the fair value hierarchy (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, 2020
​ |  | Level 1 |  | Level 2 |  | Level 3
Assets (liabilities) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pension plan assets | ​ | $ | 5,598 | ​ | $ | — | ​ | $ | —
Other long-term assets | ​ |  | 4,411 | ​ |  | — | ​ |  | —
Interest rate swaps | ​ |  | — | ​ |  | (2,228) | ​ |  | —

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2019
​ |  | Level 1 |  | Level 2 |  | Level 3
Assets (liabilities) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pension plan assets | ​ | $ | 6,099 | ​ | $ | — | ​ | $ | —
Other long-term assets | ​ |  | 4,690 | ​ |  | — | ​ |  | —
Interest rate swaps | ​ |  | — | ​ |  | (363) | ​ |  | —

​

​

13. INCOME TAXES

The income tax provision for interim periods is determined using an estimate of the annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the estimate of the annual effective tax rate is updated, and if the estimated effective tax rate changes, a cumulative adjustment is made. There is a potential for volatility of the effective tax rate due to several factors, including changes in the mix of the pre-tax income and the jurisdictions to which it relates, changes in tax laws, settlements with taxing authorities and foreign currency fluctuations.

The effective income tax rate as a percentage of income before income taxes was 29.9% and 28.0% in the second quarter 2020 and 2019, respectively. The effective tax rate includes a discrete tax provision of 1.7% and tax benefit of (0.5%) for the second quarters of 2020 and 2019 respectively, related primarily to the recognition of excess tax provision and benefit for share-based payment awards. For the six months ended June 30, 2020 and 2019, the effective income tax rate as a percentage of income before income taxes was 28.8% and 27.7%, respectively. For the six months ended June 30, 2020 and 2019 the effective tax rate includes a discrete tax provision of 0.9% and benefit of (1.1%), respectively, related primarily to the recognition of excess tax provision and benefit for share-based payment awards.

The effective rate before discrete items varies from the statutory rate primarily due to differences in state taxes, the impact of international tax provisions in the US, the difference in foreign tax rates and the mix of foreign and domestic income. The increase in the effective income tax rate as a percentage of income before income taxes from second quarter 2019 to 2020 is a result of limited deductibility of executive compensation and the recognition of excess tax provision for share-based awards.

In July 2020, U.S. Department of Treasury released Final and Proposed Regulations related to the treatment of income that is subject to high rate of foreign tax under the global intangible low-taxed income (GILTI) and Subpart F income regimes. These provisions would be effective for the Company starting in 2021, but includes retroactive provisions that may allow for early adoption. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

​

14. LEASES

The Company has operating leases for office space, manufacturing equipment, computer equipment and automobiles. Many leases include one or more options to renew, some of which include options to extend the leases for a long-term period, and some leases include options to terminate the leases within 30 days. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for capital area maintenance, utilities, inflation and/or changes in other indexes.

14

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

Short term and variable lease expense were not material in any of the periods presented.

​

Supplemental cash flow information related to the Company’s operating leases for the six month period ended June 30, 2020 and 2019 was as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six months ended | ​
​ | ​ | June 30, | ​
​ | ​ | 2020 | ​ | 2019 | ​
Cash paid for amounts included in the measurement of operating leases |  | $ | 2,126 |  | $ | 2,069 |
ROU assets obtained in exchange for operating lease obligations | ​ | $ | 1,797 | ​ | $ | 185 | ​
ROU assets recorded upon adoption of ASC 842 | ​ | $ | — | ​ | $ | 20,344 | ​
ROU assets obtained in acquisitions (Note 2) | ​ | $ | 2,735 | ​ | $ | — | ​

​

​

The following table presents the maturity of the Company’s operating lease liabilities as of June 30, 2020 (in thousands):

​

​ | ​ | ​ | ​
2020 |  | $ | 2,324
2021 | ​ |  | 4,181
2022 | ​ |  | 3,372
2023 | ​ |  | 2,688
2024 | ​ |  | 2,178
2025 | ​ | ​ | 2,051
Thereafter | ​ |  | 4,413
Total undiscounted cash flows | ​ | $ | 21,207
Less: present value discount | ​ | ​ | (1,720)
Total lease liabilities | ​ | $ | 19,487

​

As of June 30, 2020, the Company had no additional significant operating or finance leases that had not yet commenced.

15. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Accumulated Other Comprehensive Income (Loss) (“AOCI”) for the quarters ended June 30, 2020 and 2019 is comprised of the following (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign Currency | ​ | ​ | ​
​ | ​ | Defined Benefit | ​ | ​ | ​ | Translation | ​ | ​ | ​
​ |  | Plan Liability |  | Cash Flow Hedges |  | Adjustment |  | Total
At March 31, 2020 | ​ | $ | (1,628) | ​ | $ | (1,365) | ​ | $ | (11,054) | ​ | $ | (14,047)
Unrealized loss on cash flow hedges | ​ | ​ | — | ​ | ​ | (588) | ​ | ​ | — | ​ | ​ | (588)
Amounts reclassified from AOCI | ​ | ​ | — | ​ | ​ | 155 | ​ | ​ | — | ​ | ​ | 155
Tax effect of cash flow hedges | ​ | ​ | — | ​ | ​ | 104 | ​ | ​ | — | ​ | ​ | 104
Foreign currency translation gain | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 1,932 | ​ | ​ | 1,932
At June 30, 2020 | ​ | $ | (1,628) | ​ | $ | (1,694) | ​ | $ | (9,122) | ​ | $ | (12,444)

​

​

15

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign Currency | ​ | ​ | ​
​ | ​ | Defined Benefit | ​ | ​ | ​ | Translation | ​ | ​ | ​
​ |  | Plan Liability |  | Cash Flow Hedges |  | Adjustment |  | Total
At March 31, 2019 | ​ | $ | (1,006) | ​ | $ | 172 | ​ | $ | (8,833) | ​ | $ | (9,667)
Unrealized loss on cash flow hedges | ​ | ​ | — | ​ | ​ | (515) | ​ | ​ | — | ​ | ​ | (515)
Amounts reclassified from AOCI | ​ | ​ | — | ​ | ​ | (49) | ​ | ​ | — | ​ | ​ | (49)
Tax effect of cash flow hedges | ​ | ​ | — | ​ | ​ | 128 | ​ | ​ | — | ​ | ​ | 128
Foreign currency translation gain | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 548 | ​ | ​ | 548
At June 30, 2019 | ​ | $ | (1,006) | ​ | $ | (264) | ​ | $ | (8,285) | ​ | $ | (9,555)

​

AOCI for the six months ended June 30, 2020 and 2019 is comprised of the following (in thousands):

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign Currency | ​ | ​ | ​
​ | ​ | Defined Benefit | ​ | ​ | ​ | Translation | ​ | ​ | ​
​ |  | Plan Liability |  | Cash Flow Hedges |  | Adjustment |  | Total
At December 31, 2019 | ​ | $ | (1,628) | ​ | $ | (277) | ​ | $ | (8,626) | ​ | $ | (10,531)
Unrealized loss on cash flow hedges | ​ | ​ | — | ​ | ​ | (2,051) | ​ | ​ | — | ​ | ​ | (2,051)
Amounts reclassified from AOCI | ​ | ​ | — | ​ | ​ | 186 | ​ | ​ | — | ​ | ​ | 186
Tax effect of cash flow hedges | ​ | ​ | — | ​ | ​ | 448 | ​ | ​ | — | ​ | ​ | 448
Foreign currency translation loss | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (496) | ​ | ​ | (496)
At June 30, 2020 | ​ | $ | (1,628) | ​ | $ | (1,694) | ​ | $ | (9,122) | ​ | $ | (12,444)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Foreign Currency | ​ | ​ | ​
​ | ​ | Defined Benefit | ​ | ​ | ​ | Translation | ​ | ​ | ​
​ |  | Plan Liability |  | Cash Flow Hedges |  | Adjustment |  | Total
At December 31, 2018 | ​ | $ | (1,006) | ​ | $ | 434 | ​ | $ | (7,946) | ​ | $ | (8,518)
Unrealized loss on cash flow hedges | ​ | ​ | — | ​ | ​ | (806) | ​ | ​ | — | ​ | ​ | (806)
Amounts reclassified from AOCI | ​ | ​ | — | ​ | ​ | (101) | ​ | ​ | — | ​ | ​ | (101)
Tax effect of cash flow hedges | ​ | ​ | — | ​ | ​ | 209 | ​ | ​ | — | ​ | ​ | 209
Foreign currency translation loss | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (339) | ​ | ​ | (339)
At June 30, 2019 | ​ | $ | (1,006) | ​ | $ | (264) | ​ | $ | (8,285) | ​ | $ | (9,555)

​

The realized losses relating to the Company’s interest rate swap hedges were reclassified from accumulated other comprehensive income (loss) and included in interest expense in the condensed consolidated statements of income and comprehensive income.

16. DIVIDENDS PER SHARE

The Company declared a quarterly dividend of $0.03 per share in each of the first and second quarters of 2020 and 2019. Total dividends declared were $582 and $575 in the six months ended June 30, 2020 and 2019, respectively.

17. EARNINGS PER SHARE

Basic and diluted weighted-average shares outstanding are as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​ | Six months ended | ​
​ | ​ | June 30, | ​ | June 30, | ​
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019 |
Basic weighted average shares outstanding |  | 9,509 |  | 9,408 |  | 9,474 |  | 9,378 |
Dilutive effect of equity awards |  | 27 |  | 48 |  | 44 |  | 41 |
Diluted weighted average shares outstanding |  | 9,536 |  | 9,456 |  | 9,518 |  | 9,419 |

​

For the three and six months ended June 30, 2020 and 2019, the anti-dilutive common shares excluded from the calculation of diluted earnings per share were immaterial.

16

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

18. SEGMENT INFORMATION

The Company operates in one segment for the manufacture and marketing of controlled motion products for original equipment manufacturers and end user applications. The Company’s chief operating decision maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services in which the entity holds material assets and reports revenue.

Financial information related to the foreign subsidiaries is summarized below (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​ | Six months ended | ​
​ | ​ | June 30, | ​ | June 30, | ​
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019 |
Revenues derived from foreign subsidiaries | ​ | $ | 39,350 | ​ | $ | 29,985 | ​ | $ | 75,363 | ​ | $ | 64,567 | ​

​

Identifiable foreign assets were $121,801 and $95,777 as of June 30, 2020 and December 31, 2019, respectively.

Revenues derived from foreign subsidiaries and identifiable assets outside of the United States are primarily attributable to Europe.

Sales to customers outside of the United States by all subsidiaries were $43,372 and $38,802 during the quarters ended June 30, 2020 and 2019, respectively, and $86,762 and $82,485 for the six months ended June 30, 2020 and 2019, respectively.

For second quarter 2020 and 2019, one customer accounted for 11% and 15% of revenues, respectively, and for the six months ended June 30, 2020 and 2019 for 12% and 16% of revenues, respectively. As of June 30, 2020 and December 31, 2019 this customer represented 15% and 17% of trade receivables, respectively.

19. RECENT ACCOUNTING PRONOUNCEMENTS

Recently adopted accounting pronouncements

In June 2016, FASB issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This guidance requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. This guidance also requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses. The new guidance is effective for fiscal years beginning after December 15, 2019. The Company adopted this ASU on January 1, 2020 applying the modified retrospective approach and the adoption did not have a material impact on its condensed consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The guidance in ASU 2017-04 eliminates the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in the new ASU, goodwill impairment testing will be performed by comparing the fair value of the reporting unit with its carrying amount and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. ASU 2017-04 is effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company adopted this standard on January 1, 2020 on a prospective basis and the adoption did not have a material impact on its condensed consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820), which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019. The Company has not historically had any transfers

17

Table of Contents

ALLIED MOTION TECHNOLOGIES INC.

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

​

between Level 1 and Level 2 or assets or liabilities measured at fair value under Level 3. The Company adopted this ASU on January 1, 2020 on a prospective basis and the adoption did not have a material impact on its condensed consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This guidance provides relief for impacted areas as it relates to impending reference rate reform and contains optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other areas or transactions, subject to meeting certain criteria, that are impacted by reference rate reform. This ASU is effective upon issuance for all entities and elections of certain optional expedients are required to apply the provisions of the guidance. The Company adopted this ASU effective January 1, 2020 on a prospective basis, and the Company has elected the expedients related to the probability of hedged interest payments, regardless of any expected future modification in terms related to reference rate reform, as well as the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Should the Company elect further optional expedients as it relates to reference rate reform, disclosure of those elections will be done in the fiscal period in which the elections are made. The adoption did not have a material impact on its condensed consolidated financial statements.

​

​

18

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

All statements contained herein that are not statements of historical fact constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements, and may contain the word “believe,” “anticipate,” “expect,” “project,” “intend,” “will continue,” “will likely result,” “should” or words or phrases of similar meaning. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from the expected results described in the forward-looking statements. The risks and uncertainties include those associated with: the domestic and foreign general business and economic conditions in the markets we serve, including political and currency risks and adverse changes in local legal and regulatory environments; the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses’ and governments’ responses to the pandemic on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains; our inability to predict the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives: the introduction of new technologies and the impact of competitive products; the ability to protect the Company’s intellectual property; our ability to sustain, manage or forecast its growth and product acceptance to accurately align capacity with demand; the continued success of our customers and the ability to realize the full amounts reflected in our order backlog as revenue; the loss of significant customers or the enforceability of the Company’s contracts in connection with a merger, acquisition, disposition, bankruptcy, or otherwise; our ability to meet the technical specifications of our customers; the performance of subcontractors or suppliers and the continued availability of parts and components; changes in government regulations; the availability of financing and our access to capital markets, borrowings, or financial transactions to hedge certain risks; the ability to attract and retain qualified personnel who can design new applications and products for the motion industry; the ability to implement our corporate strategies designed for growth and improvement in profits including to identify and consummate favorable acquisitions to support external growth and the development of new technologies; the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems; our ability to control costs, including the establishment and operation of low cost region manufacturing and component sourcing capabilities; and the additional risk factors discussed under “Item 1A. Risk Factors” in Part II of this report and in the Company’s Annual Report in Form 10-K. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on these forward- looking statements as a prediction of actual results. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward-looking statements, whether as a result of new information, future events, or otherwise.

New risk factors emerge from time to time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company’s expectations, beliefs and projections are believed to have a reasonable basis; however, the Company makes no assurance that expectations, beliefs or projections will be achieved.

Overview

We are a global company that designs, manufactures and sells precision and specialty controlled motion components and systems used in a broad range of industries. Our target markets include Vehicle, Medical, Aerospace & Defense, and Industrial. We are headquartered in Amherst, NY, and have operations in the United States, Canada, Mexico, Europe and Asia-Pacific. We are known worldwide for our expertise in electro-magnetic, mechanical and electronic motion technology. We sell component and integrated controlled motion solutions to end customers and OEMs through our own direct sales force and authorized manufacturers’ representatives and distributors. Our products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products.

Business Environment

The ongoing outbreak of the novel strain of Coronavirus (“COVID-19”) has resulted, and will continue to result, in significant disruptions to the U.S. and global economies and has and will adversely affect our business, including our supply chain and operations. We also have experienced, and expect to continue to experience, reductions in customer demand in several of our served

19

Table of Contents

markets, primarily Vehicle. During the second quarter, the impact of the social distancing measures, the reduced operational status of our suppliers and reductions in production at certain facilities has impacted our operations more significantly than in the first quarter. We expect general business uncertainty will continue to negatively impact demand in several of our served markets in the third quarter and beyond. During the first half of 2020, the impact of COVID-19 on our operations was most pronounced in areas that serve our Vehicle market.

In response to the worldwide outbreak, we have taken proactive, aggressive action to protect the health and safety of our employees, customers, partners and suppliers. We enacted rigorous safety measures in all of our sites, including implementing social distancing protocols, requiring work from home for those employees that do not need to be physically present on the manufacturing floor or in a lab to perform their work, suspending travel, implementing temperature checks at the entrances to our facilities, extensively and frequently disinfecting our workspaces and providing masks and other protective equipment to those employees who must be physically present. We have implemented these measures on a worldwide basis and are continuing to monitor government authorities requirements or recommendations. We will continue to act in the best interests of our employees, customers, partners, suppliers and communities.

We have responded to the outbreak with a recognition that our Company provides essential and important products that our customers rely on to address this crisis. We manufacture and deliver critical motion control components, including electronic drives, motors and control assemblies to manufacturers of medical equipment including respirators, ventilators, infusion pumps, medical fluid pumps and other breathing assist equipment required to care for patients with respiratory issues including the coronavirus. We are also a long-term, qualified supplier to leading medical device manufacturers of ventilators and respirators around the world.

Global demand and capacity to produce ventilators has increased significantly and we are a reliable supplier of the critical motion control components it requires.

We also continue to provide solutions to suppliers of other types of medical equipment including surgical tools and equipment, surgical robots, diagnostic equipment, test equipment, patient mobility and rehabilitation equipment, hospital beds and mobile equipment carts. The Company has rapidly deployed resources to increase production capacity to meet the surge in demand for certain types of medical products, related to combatting the COVID-19 virus.

Our worldwide locations are considered to be essential suppliers to our customers and therefore most of our locations have remained substantially operational during the outbreak while implementing the enhanced safety procedures. Our facility in China was shut down for a small portion of the first quarter but since then has continued to be fully operational. Our facility in Reynosa, Mexico experienced brief shutdowns in the second quarter and is also currently fully operational.

We took actions in the first and second quarters to strengthen our liquidity and financial condition. In February 2020, we renewed and increased our revolving credit facility (“Amended Revolving Facility”) to $225 million through February 2025 (refer to Note 10, “Debt Obligations” from our condensed consolidated financial statements). Through this amendment we lowered our cost of debt, and secured more favorable covenants. While part of our pre-COVID-19 planning, this liquidity preserves our financial flexibility during the pandemic. During the second quarter, we were able to paydown debt while maintaining a robust cash balance to cover our short-term needs. We believe that our cash flows from operations and borrowing capacity are sufficient to support our short and long-term liquidity needs.

To conserve cash while supporting growth plans, we continue to align variable costs with demand, maintaining key engineering capabilities, freezing hiring activity and wages and tightly controlling discretionary spending.

The extent of the impact of the COVID-19 outbreak on our operational and financial performance will depend on certain developments, including the duration and spread of the virus, its impact on our customers and the range of governmental reactions to the pandemic, which cannot be predicted at this time. We will continue to proactively respond to the situation and will take further actions as warranted to alter our business operations as necessary.

20

Table of Contents

Operating Results

Quarter ended June 30, 2020 compared to quarter ended June 30, 2019

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the quarter ended |  | 2020 vs. 2019 | ​
​ | ​ | June 30, | ​ | Variance |
(Dollars in thousands, except per share data) |  | 2020 |  | 2019 | ​ | $ |  | % | ​
Revenues | ​ | $ | 86,661 | ​ | $ | 92,630 | ​ | $ | (5,969) | ​ | (6) | %
Cost of goods sold | ​ |  | 60,201 | ​ |  | 64,208 | ​ |  | (4,007) | ​ | (6) | %
Gross profit | ​ |  | 26,460 | ​ |  | 28,422 | ​ |  | (1,962) | ​ | (7) | %
Gross margin percentage | ​ |  | 30.5 | % |  | 30.7 | % |  |  | ​ |  | ​
Operating costs and expenses: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  | ​
Selling | ​ |  | 3,842 | ​ |  | 4,136 | ​ |  | (294) | ​ | (7) | %
General and administrative | ​ |  | 9,710 | ​ |  | 9,569 | ​ |  | 141 | ​ | 1 | %
Engineering and development | ​ |  | 6,197 | ​ |  | 5,676 | ​ |  | 521 | ​ | 9 | %
Business development | ​ |  | 177 | ​ |  | 3 | ​ |  | 174 | ​ | 5,800 | %
Amortization of intangible assets | ​ |  | 1,483 | ​ |  | 1,430 | ​ |  | 53 | ​ | 4 | %
Total operating costs and expenses | ​ |  | 21,409 | ​ |  | 20,814 | ​ |  | 595 | ​ | 3 | %
Operating income | ​ |  | 5,051 | ​ |  | 7,608 | ​ |  | (2,557) | ​ | (34) | %
Interest expense | ​ |  | 901 | ​ |  | 1,435 | ​ |  | (534) | ​ | (37) | %
Other expense (income) | ​ |  | 17 | ​ |  | (1) | ​ |  | 18 | ​ | (1,800) | %
Total other expense | ​ |  | 918 | ​ |  | 1,434 | ​ |  | (516) | ​ | (36) | %
Income before income taxes | ​ |  | 4,133 | ​ |  | 6,174 | ​ |  | (2,041) | ​ | (33) | %
Provision for income taxes | ​ |  | (1,237) | ​ |  | (1,729) | ​ |  | 492 | ​ | (28) | %
Net income | ​ | $ | 2,896 | ​ | $ | 4,445 | ​ | $ | (1,549) | ​ | (35) | %
​ | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  | ​
Effective tax rate | ​ |  | 29.9 | % |  | 28.0 | % |  | 1.9 | % | 7 | %
Diluted earnings per share | ​ | $ | 0.30 | ​ | $ | 0.47 | ​ | $ | (0.17) | ​ | (36) | %
Bookings | ​ | $ | 80,365 | ​ | $ | 95,317 | ​ | $ | (14,952) | ​ | (16) | %
Backlog | ​ | $ | 127,701 | ​ | $ | 133,507 | ​ | $ | (5,806) | ​ | (4) | %

​

REVENUES: For the quarter, the decrease in revenues reflects the impact of declines in the markets we serve due to recent market conditions resulting from the disruptions caused by COVID-19. The addition of revenues from Dynamic Controls bolstered our strong Medical market revenues during the quarter. This increase was offset by declines in many of the markets we serve, most notably in our Vehicle market.

​

Sales to U.S. customers were 50% of total sales for the second quarter 2020 compared with 58% for the same period last year, with the balance of sales to customers primarily in Europe, Canada and Asia. The overall decrease in revenue was due to a 4.9% volume decrease along with a 1.5% unfavorable currency impact. Revenue for the second quarter 2020 was slightly down compared to 2019 when excluding foreign currency impacts. See information included in “Non – GAAP Measures” below for a discussion of the non-GAAP measure and a reconciliation of revenue to revenue excluding foreign currency impacts.

​

ORDER BOOKINGS AND BACKLOG: The decrease in orders in the second quarter of 2020 compared to the second quarter of 2019 is largely due to the effect of COVID-19 on the markets we serve along with unfavorable foreign currency impacts. The decrease in backlog as of June 30, 2020, compared to at June 30, 2019 was also related to these factors.

​

GROSS PROFIT AND GROSS MARGIN: Gross margin decreased to 30.5% for the second quarter of 2020, compared to 30.7% for the second quarter of 2019. The decrease is primarily due to a decrease in sales due to the effect of COVID-19 on the markets we serve. The higher gross margin from our Medical market sales was more than offset by lower volumes in our lower margin Vehicle sales.

​

SELLING EXPENSES: Selling expenses declined in the second quarter of 2020 compared to the same period of 2019. The addition of Dynamic Controls was offset by cost control efforts related to the COVID-19 pandemic. Selling expenses as a percentage of revenues were 4.4% in the second quarter of 2020 compared to 4.5% for the same period last year.

​

21

Table of Contents

GENERAL AND ADMINISTRATIVE EXPENSES: General and administrative expenses increased by 1% in the second quarter 2020 from the second quarter 2019 due to the incremental expenses from Dynamic Controls and costs associated with ensuring employee safety and making other adjustments for COVID-19, partially offset by reduced incentive compensation. As a percentage of revenues, general and administrative expenses were 11.2% for the quarter ended June 30, 2020 compared to 10.3% for the same period in 2019.

​

ENGINEERING AND DEVELOPMENT EXPENSES: Engineering and development expenses increased by 9% in the second quarter of 2020 compared to the same quarter last year. Part of the increase relates to the addition of Dynamic Controls, whose focus is electronics and software engineering. The increase is also due to the continued ramp up of development projects to meet the future needs of target markets, as well as supporting growing customer application development needs. As a percentage of revenues, engineering and development expenses were 7.2% and 6.1% for the second quarters of 2020 and 2019, respectively.

​

BUSINESS DEVELOPMENT COSTS: The Company incurred $177 of business development costs in the second quarter 2020 compared to $3 of business development costs in the second quarter last year. The costs in 2020 relate to activity from the acquisition of Dynamic Controls.

​

INTEREST EXPENSE: Interest expense decreased in the second quarter 2020 as the increase in our outstanding debt balance was offset by lower interest rates compared to the same period in 2019.

​

AMORTIZATION OF INTANGIBLE ASSETS: Amortization expense increased 4% to $1,483 in the second quarter of 2020 compared to the second quarter of 2019 due to the additional intangible assets acquired in the acquisition of Dynamic Controls.

​

INCOME TAXES: The effective income tax rate as a percentage of income before income taxes was 29.9% and 28.0% in the second quarter 2020 and 2019, respectively. The effective tax rate is impacted by a discrete tax provision of 1.7% and a benefit of (0.5%) for the second quarters of 2020 and 2019, respectively, related primarily to the recognition of excess tax provision and benefits for share-based payment awards. The effective rate before discrete items varies from the statutory rate primarily due to differences in state taxes, the impact of international tax provisions in the U.S., the difference in foreign tax rates and the mix of foreign and domestic income.

​

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act is a sweeping stimulus bill intended to bolster the U.S. economy, among other things, and provide emergency assistance to qualifying businesses and individuals. The Company is continuing to evaluate the impact of the CARES Act, however there was not a significant impact on the provision for income taxes during the quarter ended June 30, 2020.

​

NET INCOME: Net income decreased during the second quarter 2020 compared to the second quarter 2019 reflecting lower revenue resulting from the disruptions caused by COVID-19 and increased operating expenses as a result of the Dynamic Controls acquisition.

​

EBITDA AND ADJUSTED EBITDA: EBITDA was $8,911 for the second quarter of 2020 compared to $11,277 for the same quarter last year. Adjusted EBITDA was $10,019 and $12,146 for the second quarters of 2020 and 2019, respectively. EBITDA and Adjusted EBITDA are non-GAAP measurements. EBITDA consists of income before interest expense, provision for income taxes, and depreciation and amortization. Adjusted EBITDA also excludes stock compensation expense and certain other items. Refer to information included in “Non-GAAP Measures” below for a reconciliation of net income to EBITDA and Adjusted EBITDA.

​

22

Table of Contents

Six months ended June 30, 2020 compared to six months ended June 30, 2019

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the six months ended |  | 2020 vs. 2019 | ​
​ | ​ | June 30, | ​ | Variance |
(Dollars in thousands, except per share data) |  | 2020 |  | 2019 | ​ | $ |  | % | ​
Revenues | ​ | $ | 179,043 | ​ | $ | 186,526 | ​ | $ | (7,483) | ​ | (4) | %
Cost of goods sold | ​ |  | 124,541 | ​ |  | 130,442 | ​ |  | (5,901) | ​ | (5) | %
Gross profit | ​ |  | 54,502 | ​ |  | 56,084 | ​ |  | (1,582) | ​ | (3) | %
Gross margin percentage | ​ |  | 30.4 | % |  | 30.1 | % |  |  | ​ |  | ​
Operating costs and expenses: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  | ​
Selling | ​ |  | 8,085 | ​ |  | 8,229 | ​ |  | (144) | ​ | (2) | %
General and administrative | ​ |  | 18,872 | ​ |  | 18,519 | ​ |  | 353 | ​ | 2 | %
Engineering and development | ​ |  | 12,431 | ​ |  | 11,483 | ​ |  | 948 | ​ | 8 | %
Business development | ​ |  | 424 | ​ |  | 56 | ​ |  | 368 | ​ | 657 | %
Amortization of intangible assets | ​ |  | 2,924 | ​ |  | 2,862 | ​ |  | 62 | ​ | 2 | %
Total operating costs and expenses | ​ |  | 42,736 | ​ |  | 41,149 | ​ |  | 1,587 | ​ | 4 | %
Operating income | ​ |  | 11,766 | ​ |  | 14,935 | ​ |  | (3,169) | ​ | (21) | %
Interest expense | ​ |  | 1,955 | ​ |  | 2,615 | ​ |  | (660) | ​ | (25) | %
Other expense (income), net | ​ |  | 76 | ​ |  | (19) | ​ |  | 95 | ​ | (500) | %
Total other expense, net | ​ |  | 2,031 | ​ |  | 2,596 | ​ |  | (565) | ​ | (22) | %
Income before income taxes | ​ |  | 9,735 | ​ |  | 12,339 | ​ |  | (2,604) | ​ | (21) | %
Provision for income taxes | ​ |  | (2,804) | ​ |  | (3,424) | ​ |  | 620 | ​ | (18) | %
Net income | ​ | $ | 6,931 | ​ | $ | 8,915 | ​ | $ | (1,984) | ​ | (22) | %
​ | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  | ​
Effective tax rate | ​ |  | 28.8 | % |  | 27.7 | % |  | 1 | ​ | 4 | %
Diluted earnings per share | ​ | $ | 0.73 | ​ | $ | 0.95 | ​ | $ | (0.22) | ​ | (23) | %
Bookings | ​ | $ | 173,288 | ​ | $ | 189,061 | ​ | $ | (15,773) | ​ | (8) | %
Backlog | ​ | $ | 127,701 | ​ | $ | 133,507 | ​ | $ | (5,806) | ​ | (4) | %

​

REVENUES: For year to date 2020, the decrease in revenues reflects the impact of declines in the markets we serve due to recent market conditions. The addition of revenues from Dynamic Controls to our Medical market were more than offset by declines in many of the markets we serve, most notably in our Vehicle market.

​

Sales to U.S. customers were 52% of total sales for the six months ended June 30, 2020 compared with 56% for the same period last year, with the balance of sales to customers primarily in Europe, Canada and Asia. The overall decrease in revenue was due to a 2.5% volume decrease along with a 1.5% unfavorable currency impact. Revenue for the year to date 2020 was comparable to 2019 when excluding foreign currency impacts. See information included in “Non–GAAP Measures” below for a discussion of the non-GAAP measure and reconciliation of revenue to revenue excluding foreign currency impacts.

​

ORDER BOOKINGS AND BACKLOG: The decrease in orders and backlog in the six months ended June 30, 2020 compared to the six months ended June 30, 2019 is largely due to the effect of COVID-19 on the markets we serve along with unfavorable foreign currency impacts.

​

GROSS PROFIT AND GROSS MARGIN: Gross margin increased to 30.4% for the first half of 2020, compared to 30.1% for the comparable period of 2019. The increase reflects sales of higher margin Medical market products during the quarter, enhanced by the reduction in Vehicle sales that tend to have lower margins.

​

SELLING EXPENSES: Selling expenses declined during the six months ended June 30, 2020 compared to the same period of 2019. The addition of expenses from Dynamic Controls was offset by cost control efforts related to the COVID-19 pandemic. Selling expenses as a percentage of revenues were 4.5% in the first half of 2020 compared to 4.4% for the same period last year.

​

GENERAL AND ADMINISTRATIVE EXPENSES: General and administrative expenses increased by 2% in the first half of 2020 from the first half of 2019 due to the incremental expenses from Dynamic Controls partially offset by reduced incentive compensation. As a percentage of revenues, general and administrative expenses were 10.5% for the six months ended June 30, 2020 compared to 9.9% for the same period in 2019.

​

23

Table of Contents

ENGINEERING AND DEVELOPMENT EXPENSES: Engineering and development expenses increased by 8% in the first half of 2020 compared to the same period last year reflecting the acquisition of Dynamic Controls. As a percentage of revenues, engineering and development expenses were 6.9% and 6.2% for the six months ended June 30, 2020 and 2019, respectively.

​

BUSINESS DEVELOPMENT COSTS: The Company incurred $424 of business development costs in the first half of 2020 compared to $56 of business development costs in the first half last year. The costs in 2020 relate to activity from the acquisition of Dynamic Controls.

​

INTEREST EXPENSE: Interest expense decreased in the first six months of 2020 as the increase in our outstanding debt was offset by lower interest rates compared to the same period in 2019.

​

AMORTIZATION OF INTANGIBLE ASSETS: Amortization expense increased 2% during the first half of 2020 compared to the same period of 2019 due to the addition of Dynamic Controls.

​

INCOME TAXES: The effective income tax rate as a percentage of income before income taxes was 28.8% and 27.7% in the first half 2020 and 2019, respectively. The effective tax rate includes a discrete tax provision of 0.9% and benefit of (1.1%) for the first six months of 2020 and 2019, respectively, related primarily to the recognition of excess tax provision and benefits for share-based payment awards. The effective rate before discrete items varies from the statutory rate primarily due to differences in state taxes, the impact of international tax provisions in the U.S., the difference in foreign tax rates and the mix of foreign and domestic income.

​

The Company is continuing to evaluate the impact of the CARES Act, however there was not a significant impact on the provision for income taxes during the period ended June 30, 2020.

​

NET INCOME: Net income decreased during the six months ended June 30, 2020 compared to the six months ended June 30, 2019 reflecting lower revenue resulting from the disruptions caused by COVID-19 and increased operating expenses as a result of the Dynamic Controls acquisition.

​

EBITDA AND ADJUSTED EBITDA: EBITDA was $19,317 for the six months ended June 30, 2020 compared to $22,281 for the six months ended June 30, 2019. Adjusted EBITDA was $21,461 and $23,877 for the first six months of 2020 and 2019, respectively. EBITDA and Adjusted EBITDA are non-GAAP measurements. EBITDA consists of income before interest expense, provision for income taxes, and depreciation and amortization. Adjusted EBITDA also excludes stock compensation expense and certain other items. Refer to information included in “Non-GAAP Measures” below for a reconciliation of net income to EBITDA and Adjusted EBITDA.

Non-GAAP Measures

EBITDA and Adjusted EBITDA are provided for information purposes only and are not measures of financial performance under GAAP.

Management believes the presentation of these financial measures reflecting non-GAAP adjustments provides important supplemental information in evaluating the operating results of the Company as distinct from results that include items that are not indicative of ongoing operating results; in particular, those charges and credits that are not directly related to operating unit performance, and that are not a helpful measure of the performance of our underlying business particularly in light of their unpredictable nature. These non-GAAP disclosure have limitations as analytical tools, should not be viewed as a substitute for revenue and net income determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP, nor is it necessarily comparable to non-GAAP performance measures that may be presented by other companies. In addition, supplemental presentation should not be construed as an inference that the Company’s future results will be unaffected by similar adjustments to net income determined in accordance with GAAP.

The Company believes EBITDA is often a useful measure of a Company’s operating performance and is a significant basis used by the Company’s management to measure the operating performance of the Company’s business because EBITDA excludes charges for depreciation, amortization and interest expense that have resulted from our debt financings, acquisitions, as well as our provision for income tax expense. EBITDA is frequently used as one of the basis for comparing businesses in the Company’s industry.

The Company believes that revenue excluding foreign currency exchange impacts is a useful measure in analyzing organic sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not

24

Table of Contents

under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period.

The Company also believes that Adjusted EBITDA provides helpful information about the operating performance of its business. Adjusted EBITDA excludes stock compensation expense, as well as certain income or expenses which are not indicative of the ongoing performance of the Company. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.

The Company’s calculation of revenues excluding foreign currency exchange impacts for the three and six months ended June 30, 2020 is as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended | ​ | Six months ended |
​ |  | June 30, 2020 |  | June 30, 2020 |
Revenue as reported | ​ | $ | 86,661 | ​ | $ | 179,043 | ​
Currency impact | ​ |  | 1,381 | ​ |  | 2,804 | ​
Revenue excluding foreign currency exchange impacts | ​ | $ | 88,042 | ​ | $ | 181,847 | ​

​

The Company’s calculation of EBITDA and Adjusted EBITDA for the three and six months ended June 30, 2020 and 2019 is as follows (in thousands):

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three months ended |  | Six months ended
​ | ​ | June 30, | ​ | June 30,
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019
Net income as reported | ​ | $ | 2,896 | ​ | $ | 4,445 | ​ | $ | 6,931 | ​ | $ | 8,915
Interest expense | ​ |  | 901 | ​ |  | 1,435 | ​ |  | 1,955 | ​ |  | 2,615
Provision for income tax | ​ |  | 1,237 | ​ |  | 1,729 | ​ |  | 2,804 | ​ |  | 3,424
Depreciation and amortization | ​ |  | 3,877 | ​ |  | 3,668 | ​ |  | 7,627 | ​ |  | 7,327
EBITDA | ​ |  | 8,911 | ​ |  | 11,277 | ​ |  | 19,317 | ​ |  | 22,281
Stock compensation expense | ​ |  | 931 | ​ |  | 866 | ​ |  | 1,720 | ​ |  | 1,540
Business development costs | ​ |  | 177 | ​ |  | 3 | ​ |  | 424 | ​ |  | 56
Adjusted EBITDA | ​ | $ | 10,019 | ​ | $ | 12,146 | ​ | $ | 21,461 | ​ | $ | 23,877

​

Liquidity and Capital Resources

On February 12, 2020, we entered into a First Amended and Restated Credit Agreement (the “Amended Credit Agreement”) for a $225 million revolving credit facility (the “Amended Revolving Facility”) with HSBC Bank USA and affiliate banks (refer to Note 10, “Debt Obligations” from our condensed consolidated financial statements). The term of the Amended Credit Agreement was extended to February 2025 from the original term of October 2021.

The Company’s liquidity position as measured by cash and cash equivalents increased by $5,603 to a balance of $19,019 at June 30, 2020 from December 31, 2019.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​ | ​ | 2020 vs. |
​ | ​ | Six Months Ended | ​ | 2019 | ​
​ | ​ | June 30, | ​ | Variance | ​
​ |  | 2020 |  | 2019 |  | $ |
Net cash provided by operating activities | ​ | $ | 6,599 | ​ | $ | 8,852 | ​ | $ | (2,253) | ​
Net cash used in investing activities | ​ | ​ | (18,342) |  | ​ | (6,401) | ​ |  | (11,941) | ​
Net cash provided by (used in) financing activities | ​ | ​ | 17,275 |  | ​ | (620) | ​ |  | 17,895 | ​
Effect of foreign exchange rates on cash | ​ | ​ | 71 |  | ​ | (41) | ​ |  | 112 | ​
Net increase in cash and cash equivalents | ​ | $ | 5,603 | ​ | $ | 1,790 | ​ | $ | 3,813 | ​

​

25

Table of Contents

During the six months ended June 30, 2020, the decrease in cash provided by operating activities is primarily due to the decrease in net income in 2020 compared to 2019. In addition, inventories in 2020 increased during the six months ended June 30, 2020 due to the push out of orders from our Vehicle market customers.

The significant cash used in investing activities in the first half of 2020 reflects the acquisition of Dynamic Controls for $14,728 net of cash acquired. Purchases of property and equipment were $3,614 during the six months ended June 30, 2020 compared to $6,401 during the six months ended June 30, 2019 reflecting cost containment efforts during the COVID-19 pandemic. Capital expenditures are expected to be between $10,000 and $12,000 for 2020, consistent with amounts previously disclosed.

The increase in cash provided by financing activities reflects the Amended Revolving Facility borrowing for the acquisition of Dynamic Controls. During 2019, the Company utilized revolver borrowings to fund working capital to support the growth seen from fourth quarter 2018 along with the payment of normal year-end accruals during the first quarter of 2019. At June 30, 2020, we had $129,099 of obligations under the Amended Revolving Facility, excluding deferred financing costs.

The Amended Credit Agreement contains certain financial covenants related to minimum interest coverage and total leverage ratio at the end of each quarter. The Amended Credit Agreement also includes other covenants and restrictions, including limits on the amount of additional indebtedness, and restrictions on the ability to merge, consolidate or sell all or substantially all our assets. We were in compliance with all covenants at June 30, 2020.

As of June 30, 2020, the unused Amended Revolving Facility was $95,901. The amount available to borrow may be lower and may vary from period to period based upon our debt and EBITDA levels, which impacts our covenant calculations. The Amended Credit Agreement matures in February 2025.

There were no borrowings for the China Facility balance during the first half of 2020 or 2019.

The Company declared dividends of $0.03 per share during the first and second quarters of both 2020 and 2019.

​

Although there is uncertainty related to the anticipated impact of the recent COVID-19 outbreak on our future results, we believe our business model and the steps we have taken to strengthen our balance sheet, such as retaining cash to support shorter term needs and extending the maturity of our revolving credit facility leaves us well-positioned to manage our business through this crisis as it continues to unfold. We have reviewed numerous potential scenarios in connection with the impact of COVID-19 on our Company. Based on our analysis, we believe our existing balances of cash, the flexibility of our Amended Credit Agreement and our currently anticipated operating cash flows will be sufficient to meet our cash needs arising in the ordinary course of business for the next twelve months.

​

Item 3. Qualitative and Quantitative Disclosures about Market Risk

Foreign Currency

We have foreign operations in The Netherlands, Sweden, Germany, China, Portugal, Czech Republic, Canada, Mexico, the United Kingdom and New Zealand which expose the Company to foreign currency exchange rate fluctuations due to transactions denominated in Euros, Swedish Krona, Chinese Renminbi, Czech Krona, Canadian dollar, Mexican pesos, British Pound Sterling and New Zealand dollar, respectively. We continuously evaluate our foreign currency risk and will take action from time to time in order to best mitigate these risks. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency exposures would have had an impact of approximately $3,900 on our second quarter 2020 sales and $7,500 on our sales for the six months ended June 30, 2020. This amount is not indicative of the hypothetical net earnings impact due to partially offsetting impacts on cost of sales and operating expenses in those currencies. We estimate that foreign currency exchange rate fluctuations during the quarter ended June 30, 2020 decreased sales in comparison to quarter ended June 30, 2019 by approximately $1,380. On a year to date basis, we estimate that foreign currency exchange rate fluctuations decreased sales $2,800 in 2020 compared to 2019.

We translate all assets and liabilities of our foreign operations, where the U.S. dollar is not the functional currency, at the period-end exchange rate and translate sales and expenses at the average exchange rates in effect during the period. The net effect of these translation adjustments is recorded in the condensed consolidated financial statements as comprehensive income. The translation adjustment was a gain of approximately $1,932 and a gain of approximately $548 for the second quarter of 2020 and 2019, respectively. For the six months ended June 30, 2020 and 2019, the translation adjustment was a loss of approximately $500 and $340, respectively. Translation adjustments are not adjusted for income taxes as they relate to permanent investments in our foreign

26

Table of Contents

subsidiaries. Net foreign currency transaction gains and losses included in other expense (income), net amounted to a loss of $118 and a gain of $19 for the second quarter of 2020 and 2019, respectively. For the six months ended June 30, 2020 and 2019, net foreign currency transaction gains and losses included in other expense, net were a loss of $210 and $58, respectively. A hypothetical 10% change in the value of the U.S. dollar in relation to our most significant foreign currency net assets would have had an impact of approximately $8,800 on our foreign net assets as of June 30, 2020.

Interest Rates

Borrowings under the Amended Revolving Facility bear interest at the LIBOR Rate plus a margin of 1.00% to 1.75% (currently 1.5%) or the Prime Rate plus a margin of 0% to 0.75% (currently 0.5%), in each case depending on the Company’s ratio of total funded indebtedness to Consolidated trailing twelve-month EBITDA. We use interest rate derivatives to add stability to interest expense and to manage our exposure to interest rate movements. We primarily use interest rate swaps as part of our interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In February 2017, the Company entered into three interest rate swaps with a combined notional amount of $40,000 that mature in February 2022. In March 2020, the Company entered into two additional interest rate swaps with a combined notional amount of $20,000 that increases to $60,000 in March 2022 and matures in December 2024.

As of June 30, 2020, we had $129,099 outstanding under the Amended Revolving Facility (excluding deferred financing fees), of which $60,000 is currently being hedged. Refer to Note 10 of the Notes to condensed consolidated financial statements for additional information about our outstanding debt. A hypothetical one percentage point (100 basis points) change in the Base Rate on the $69,099 of unhedged floating rate debt outstanding at June 30, 2020 would have approximately a $175 impact on our interest expense for the second quarter of 2020 and $350 on our interest expense for the six months ended June 30, 2020.

​

Item 4. Controls and Procedures

Conclusion regarding the effectiveness of disclosure controls and procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (principal accounting officer), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of June 30, 2020. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that, as of June 30, 2020, the Company’s disclosure controls and procedures were effective.

Changes in internal control over financial reporting

In response to the COVID-19 pandemic, many of our team members began working from home during the first quarter of 2020 and continued to do so during the second quarter of 2020. Management has taken measures to ensure that our internal controls over financial reporting remained effective and were not materially affected during this period. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

During the quarter ended June 30, 2020, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

​

27

Table of Contents

PART II. OTHER INFORMATION

Item 1A. Risk Factors

The following risk factor supplements the risk factors described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and should be read in conjunction with the risk factors described in our 2019 Form 10-K Report:

Our financial condition and results of operations have been and may continue to be adversely affected by public health issues, including epidemics or pandemics such as COVID-19. The COVID-19 pandemic has subjected our business, operations, financial performance, cash flows and financial condition to a number of risks, including, but not limited to those discussed below.

Operations-related risks: As a result of the COVID-19 pandemic, we are facing increased operational challenges from the need to protect employee health and safety, workplace disruptions and restrictions on the movement of people, raw materials and goods, both at our own facilities and at our customers and suppliers. For example, we may experience additional operating costs due to increased challenges with our workforce (including as a result of illness, absenteeism or government orders), access to necessary components and supplies, access to capital, and access to fundamental support services (such as shipping and transportation). The ultimate significance of these disruptions to our business, financial condition, results of operations, and cash flows will depend greatly on how long the disruptions continue. Any delayed recovery in our operations, and/or any similar delay with respect to resumption of operations by one or more of our key suppliers, would result in further challenges to our business and may negatively affect our business, financial condition, results of operations, and cash flows.

Customer-related risks: As a result of the COVID-19 pandemic, there may be changes in our customers’ priorities and practices, as our customers in both the United States and globally confront competing budget priorities and more limited resources. To the extent that the COVID-19 outbreak or its aftermath further impacts demand for our products and services or impairs the viability of some of our customers, our financial condition, results of operations, and cash flows could be adversely affected, and those impacts could be material.

Other risks: The magnitude and duration of the global COVID-19 pandemic is uncertain. As the pandemic continues to adversely affect portions of our business and our overall operating and financial results, it also is expected to have the effect of heightening many of the other risks described in the risk factors in our Annual Report on Form 10-K for the year ended December 31, 2019. Further, the COVID-19 pandemic may also adversely affect our operating and financial results in a manner that is not presently known to us or that we currently do not expect to present significant risks to our operations or financial results.

​

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Total Number of Shares |  | Maximum Number of Shares
​ | ​ | Number of Shares | ​ | Average Price Paid | ​ | Purchased as Part of Publicly | ​ | that May Yet Be Purchased
Period | ​ | Purchased | ​ | per Share | ​ | Announced Plans or Programs | ​ | Under the Plans or Programs
04/01/20 to 04/30/20 |  | 28,365 | (1)​ | $ | 28.09 |  | — |  | —
05/01/20 to 05/30/20 |  | — | ​ |  | — |  | — |  | —
06/01/20 to 06/30/20 |  | — | ​ |  | — |  | — |  | —
Total |  | 28,365 | ​ | $ | — |  | — |  | —

​

| (1) | As permitted under the Company’s equity compensation plan, these shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of stock. Shares withheld for tax withholding obligations do not affect the total number of shares available for repurchase under any approved common stock repurchase plan. At June 30, 2020, the Company did not have an authorized stock repurchase plan in place.

​

Item 5. Other Information

None.

​

28

Table of Contents

Item 6. Exhibits

​

| (a) | Exhibits
​ | ​ | ​
| 31.1 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 31.2 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 32.1 | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 32.2 | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
| 101.1 SCH | Inline XBRL Taxonomy Extension Schema Document (filed herewith).
​ | ​ | ​
| 101.2 CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).
​ | ​ | ​
| 101.3 DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).
​ | ​ | ​
​ | 101.4 LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (filed herewith).
​ | ​ | ​
​ | 101.5 PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).
​ | ​ | ​
​ | 104 | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in exhibits 101.*) (filed herewith).
​ | ​ | ​

​

​

29

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATE: | August 5, 2020 | ALLIED MOTION TECHNOLOGIES INC.
|  | By: | /s/ Michael R. Leach
|  | Michael R. Leach
|  | Chief Financial Officer

​

​

​

30